KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bionano Genomics (BNGO) EPS (Basic) (2017 - 2025)

Bionano Genomics (BNGO) has disclosed EPS (Basic) for 9 consecutive years, with -$0.03 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 99.62% to -$0.03 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.76 through Dec 2025, up 94.65% year-over-year, with the annual reading at -$4.85 for FY2025, 94.5% up from the prior year.
  • EPS (Basic) hit -$0.03 in Q4 2025 for Bionano Genomics, up from -$1.59 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.03 in Q4 2025 to a low of -$402.75 in Q4 2023.
  • Historically, EPS (Basic) has averaged -$25.31 across 5 years, with a median of -$1.23 in 2023.
  • Biggest five-year swings in EPS (Basic): tumbled 30880.77% in 2023 and later surged 99.62% in 2025.
  • Year by year, EPS (Basic) stood at -$0.08 in 2021, then crashed by 1525.0% to -$1.3 in 2022, then crashed by 30880.77% to -$402.75 in 2023, then soared by 98.03% to -$7.95 in 2024, then soared by 99.62% to -$0.03 in 2025.
  • Business Quant data shows EPS (Basic) for BNGO at -$0.03 in Q4 2025, -$1.59 in Q3 2025, and -$1.99 in Q2 2025.